Pharming Group (PHGUF) has released an update.
Pharming Group N.V. is set to release its third quarter financial results for 2024 on October 24, with a live presentation for analysts and investors scheduled the same day. Interested parties can register to participate in a conference call or view a live webcast via provided registration links. The company, a global biopharmaceutical entity, focuses on rare and life-threatening diseases, with operations spanning across North America, Europe, and Asia-Pacific.
For further insights into PHGUF stock, check out TipRanks’ Stock Analysis page.
